Standard Newswire is a cost-effective and efficient newswire service for public policy groups, government agencies, PR firms, think-tanks, watchdog groups, advocacy groups, coalitions, foundations, colleges, universities, activists, politicians, and candidates to distribute their press releases to journalists who truly want to hear from them.

Do not settle for an email blasting service or a newswire overloaded with financial statements. Standard Newswire gets your news into the hands of working journalists, broadcast hosts, and news producers.

Find out how you can start using Standard Newswire to

CONNECT WITH THE WORLD

VIEW ALL Our News Outlets
Sign Up to Receive Press Releases:

Standard Newswire™ LLC
209 W. 29th Street, Suite 6202
New York, NY 10001, USA.
(212) 290-1585

Brownback Opposes Obama Stem Cell Policy

Says there is no need to fund less promising, controversial, and destructive research

Contact: Brian Hart, Becky Ogilvie; both with Sam Brownback, United States Senator - Kansas, 202-224-6521

WASHINGTON, Mar. 9 /Standard Newswire/ -- U.S. Senator Sam Brownback today expressed his opposition and concern over President Obama's decision, which will be announced later today, to overturn federal funding restrictions for embryonic stem cell research.

"The Administration's policy change does not answer the central question: Do human embryos, which are clearly alive, constitute a life or mere property?" Brownback stated.  "If an embryo is a life, and I believe strongly that it is life, then no government has the right to sanction their destruction for research purposes.  If embryos are property, then they may be disposed of as their owner chooses.  I choose life and oppose the Administration's action."

After a decade of private and public research around the world, embryonic stem cell research, which requires alarming numbers of human embryos, each of which are destroyed in the process, has yet to yield any clinical trials or any real-world successes, and has to date caused serious problems including creating tumors in animal tests.

Brownback, along with many others, suggests focusing funds and efforts on non-destructive, non-controversial, and much more successful adult stem cell research, while being open to the induced Pluripotent Stem Cell technique, which allows for embryonic-type research without using or destroying human embryos.

Brownback continued, "There are exciting and numerous advances with adult stem cell research, including peer-reviewed successful human patient treatments for conditions including type-1 diabetes, spinal cord injury and Parkinson's disease.  It only makes sense to think of the patients first and focus federal dollars in these more promising areas, which do not cause serious moral concerns for many Americans."